Article Details

Genprex Signs Exclusive License to Additional Gene Therapy Technologies ... - Star Local Media

Retrieved on: 2024-11-20 15:37:02

Tags for this article:

Click the tags to see associated articles and topics

Genprex Signs Exclusive License to Additional Gene Therapy Technologies ... - Star Local Media. View article details on hiswai:

Excerpt

License includes Genprex's Reqorsa® Gene Therapy in Combination with ALK-Inhibitors for the Potential Treatment of ALK-Positive Lung Cancer.

Article found on: starlocalmedia.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up